Preview

Педиатрическая фармакология

Расширенный поиск

Сезон простуд в разгаре: лечим кашель

https://doi.org/10.15690/pf.v15i1.1845

Полный текст:

Аннотация

Острый кашель является распространенным симптомом и частым поводом обращения за медицинской помощью. Пациенты с острым кашлем нередко прибегают к самолечению с использованием безрецептурных препаратов. Однако эффективность и безопасность таких средств, как правило, не проверяется в строгих условиях клинических исследований. Более того, отмечено большое число побочных эффектов в результате применения у детей подобных препаратов. В статье разбираются вопросы целесообразности медикаментозного лечения нетяжелых случаев острой респираторной инфекции, сопровождаемой кашлем.

Об авторе

С. В. Ильина
Иркутский государственный медицинский университет
Россия

Ильина Светлана Владимировна, доктор медицинских наук, заведующая кафедрой детских инфекционных болезней.

664043, Иркутск, ул. Маршала Конева, д. 90, к. 4, тел.: +7 (3952) 30-04-46



Список литературы

1. WHO. The pursuit of responsible use of medicines: sharing and learning from country experiences [Internet]. WHO; 2012. 78 р. [cited 2017 Oct 12]. Available from: http://www.who.int/medicines/publications/responsible_use/en/

2. Worrall G. Acute cough in children. Can Fam Physician. 2011;57(3):315–318.

3. Денисова М., Сидорова И. На середине пути. Обзор российского фармацевтического рынка по итогам I полугодия 2013 г. // Ремедиум. Журнал о российском рынке лекарств и медицинской технике. — 2013. — №9 — С. 16–23. [Denisova M, Sidorova I. Half the way. Review of the pharmaceutical market in the first half of 2013. Remedium: zhurnal o rossiiskom rynke lekarstv. 2013;(9):16–23. (In Russ).]

4. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar — pediatric cough and cold medications. N Engl J Med. 2007;357(23):2321–2324. doi: 10.1056/NEJMp0707400.

5. Srinivasan A, Budnitz D, Shehab N, Cohen A. Infant deaths associated with cough and cold medications — two states, 2005. JAMA. 2007;297(8):800–801. doi: 10.1001/jama.297.8.800.

6. fda.gov [Internet]. FDA Recommends that Over-the-Counter (OTC) Cough and Cold Products not be used for Infants and Children under 2 Years of Age. 2008 [cited 2017 Nov 9]. Available from: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm051137.html

7. Lokker N, Sanders L, Perrin EM, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464–1471. doi: 10.1542/peds.2008-0854.

8. Mallet P, Mourdi N, Dubus JC, et al. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One. 2011;6(7):e22792. doi: 10.1371/journal.pone.0022792.

9. ema.europa.eu [Internet]. Revised assessment report. Ambroxol and bromhexine containing medicinal products (EMEA/H/A-31/1397) [cited 2017 Nov 9]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Ambroxol_and_bromhexine_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500184106.pdf

10. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;(11):CD001831. doi: 10.1002/14651858.CD001831.pub5.

11. Bennett S, Hoffman N, Monga M. Ephedrine- and guaifenesininduced nephrolithiasis. J Altern Complement Med. 2004;10(6):967–969. doi: 10.1089/acm.2004.10.967.

12. Friedrichsdorf SJ, Nugent AP, Strobl AQ. Codeine-associated pediatric deaths despite using recommended dosing guidelines: three case reports. J Opioid Manag. 2013;9(2):151–155. doi: 10.5055/jom.2013.0156.

13. Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006;368(9536):704. doi: 10.1016/S0140-6736(06)69255-6.

14. European Medicines Agency. Codeine not to be used in children below 12 years for cough and cold [Internet]. London, UK: European Medicines Agency; 2015. [cited 2017 Nov 9]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Codeine_cough_or_cold_in_children/Position_provided_by_CMDh/WC500186159.pdf

15. Benefit/Risk Assessment of Prescription Opioid Antitussive Products for Treatment of Cough in Pediatric Patients [Internet]. Background Document Pediatric Advisory Committee Meeting September 11, 2017 [cited 2017 Nov 9]. Available from: https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM575013.pdf

16. Dolansky G, Rieder M. What is the evidence for the safety and efficacy of over-the-counter cough and cold preparations for children younger than six years of age? Paediatr Child Health. 2008;13(2):125–127. doi: 10.1093/pch/13.2.125.

17. Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Resp Res. 2016;3(1):e000137. doi: 10.1136/bmjresp-2016-000137.

18. Bayram E, Karakaya P, Topcu Y, et al. Acute cervical dystonia after the first dose of butamirate citrate. Pediatr Emerg Care. 2013;29(1):80–81. doi: 10.1097/PEC.0b013e31827b5635.

19. Faruqi S, Wright C, Thompson R, Morice AH. A randomized placebo controlled trial to evaluate the effects of butamirate and dextromethorphan on capsaicin induced cough in healthy volunteers. Br J Clin Pharmacol. 2014;78(6):1272–1280. doi: 10.1111/bcp.12458.

20. Основы доказательной медицины. Учебное пособие / Под общей ред. Р.Г. Оганова. — М.: Силицея-Полиграф; 2010. — 136 с. [Osnovy dokazatel’noi meditsiny. Uchebnoe posobie. Ed by R.G. Oganov. Moscow: Silitseya-Poligraf; 2010. 136 p. (In Russ).]

21. Chalumeau M, Duijvestijn YCM. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev. 2013;(5):CD003124. doi: 10.1002/14651858.CD003124.pub4.

22. Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (Hedera Helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med. 2011;(2011):382789. doi: 10.1155/2011/382789.

23. Oduwole O, Meremikwu MM, Oyo-Ita A, Udoh EE. Honey for acute cough in children. Cochrane Database Syst Rev. 2014;(12):CD007094. doi: 10.1002/14651858.CD007094.pub4.

24. Mulholland S, Chang AB. Honey and lozenges for children with non-specific cough. Cochrane Database Syst Rev. 2009;(2):CD007523. doi: 10.1002/14651858.CD007523.pub2.

25. Atkinson SK, Sadofsky LR, Morice AH. How does rhinovirus cause the common cold cough? BMJ Open Resp Res. 2016;3(1):e000118. doi: 10.1136/bmjresp-2015-000118.

26. Abdullah H, Heaney LG, Cosby SL, McGarvey LP. Rhinovirus upregulates transient receptor potential channels in a human neuronal cell line: implications for respiratory virus-induced cough reflex sensitivity. Thorax. 2014;69(1):46–54. doi: 10.1136/thoraxjnl-2013-203894.

27. Morice AH, Kantar A, Dicpinigaitis PV, et al. Treating acute cough: wet versus dry — have we got the paradigm wrong? ERJ Open Res. 2015;1(2):00055-2015. doi: 10.1183/23120541.00055-2015.


Для цитирования:


Ильина С.В. Сезон простуд в разгаре: лечим кашель. Педиатрическая фармакология. 2018;15(1):75-79. https://doi.org/10.15690/pf.v15i1.1845

For citation:


Ilyina S.V. Season of Colds and Flu is in Full Swing: Treating Cough. Pediatric pharmacology. 2018;15(1):75-79. (In Russ.) https://doi.org/10.15690/pf.v15i1.1845

Просмотров: 501


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)